Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: HL pays special dividend after "extraordinary" year

Mon, 09th Aug 2021 08:26

(Alliance News) - Hargreaves Lansdown said Monday it delivered a record performance and exceptional growth during an "extraordinary and challenging year", as the fund supermarket brought in a record 233,000 net new clients in the year.

However, HL warned of higher costs in the year ahead amid new investments. The shares were down 9.6% early Monday in London, the worst FTSE 100 performer.

During the recent 12 months, Hargreaves said it benefited from market volatility that has been the "inevitable outcome" of a challenging year.

"Investor confidence started the year at a low but swung dramatically on the positive news of Covid vaccines and the political certainty provided by the US election and Brexit," said Chief Executive Officer Chris Hill.

For the financial year that ended June 30, revenue rose 15% to GBP631.0 million from GBP550.9 million last year, but pretax profit was GBP366.0 million, down 3.0% from GBP378.3 million.

The Bristol-based wealth management platform reported strong growth in assets under administration, which were up 30% to GBP135.5 billion from GBP104.0 billion. Net new business inflows were up 13% to GBP8.7 billion from GBP7.7 billion.

Hargreaves Lansdown declared a total dividend of 50.5 pence per share, down from 54.9p paid out in financial 2020. It also declared a special dividend of 12.0p.

The company said it is seeing a change in the demographic mix of its clients, with 83% of new clients under the age of 55. Further, it said it saw high levels of engagement from the "trading phenomenon around GameStop and so-called meme stocks".

Looking ahead, CEO Hill said: "With this continued investment in our people, proposition, service and technology as well as the cost of servicing an enlarged and growing client base, we expect 2022 costs to reflect this investment and continue to be broadly aligned to client growth.

"The impact of Covid on individuals, businesses and the economy still provides an uncertain backdrop to the current year. As we have eased out of lockdown and entered the summer months, we have seen a slowdown in dealing volumes and client activity versus the elevated levels this time last year, which is also normal for this time of year and in line with management expectations. However, given our enlarged client base, we would still expect to see stronger client activity in 2022 versus 2020 (which also included a few months of elevated activity during the peak of the pandemic period) and the breadth of proposition and client focus gives us confidence that as the year progresses, we will continue to win in this growing market."

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: down 0.2% at 7,106.90

----------

Hang Seng: up 0.4% at 26,290.24

Nikkei 225: Tokyo market closed for holiday.

DJIA: closed up 144.26 points, or 0.4%, at 35,208.51

S&P 500: closed up 7.42 points, or 0.2%, at 4,436.52

Nasdaq Composite: closed down 59.35 points, or 0.4%, at 14,835.76

----------

EUR: firm at USD1.1766 (USD1.1760)

GBP: up at USD1.3885 (USD1.3862)

USD: down at JPY110.12 (JPY110.30)

GOLD: down at USD1,746.42 per ounce (USD1,764.55)

OIL (Brent): down at USD69.04 a barrel (USD70.92)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Monday's Key Economic Events still to come

Japan Mountain Day holiday observed. Financial markets closed.

1100 BST Ireland industrial production

1000 EDT US employment trends index

1000 EDT US job openings

----------

A big investment plan aimed at modernizing America's infrastructure overcame a key legislative hurdle in the US Senate on Sunday, with legislation described as "historic" by President Joe Biden now almost certain to become law. The bill, months in the making, calls for USD550 billion in new federal spending on the nation's ageing infrastructure, including funds to slow the effects of climate change. The total USD1.2 trillion price tag includes some funds previously approved but not yet spent. Sunday evening saw the bill largely overcome several procedural votes in the Senate, with the slim Democratic majority bolstered by support from over a third of Republicans. It now goes to a final vote, with lawmakers primed to approve it as early as Monday if an agreement can be reached. But while there is now little doubt that the Senate will approve the almost 2,700-page text, its future is less certain in the House of Representatives, where left-wing and centrist factions have clashed over the size of the spending.

----------

BROKER RATING CHANGES

----------

MORGAN STANLEY REINITIATES ASTRAZENECA WITH 'OVERWEIGHT' - PRICE TARGET 9,800 PENCE

----------

RBC CUTS CONVATEC TO 'UNDERPERFORM' ('SECTOR PERFORM') - TARGET 213 (230) PENCE

----------

Liberum starts coverage on Made.com with Buy rating, 250p price target

----------

COMPANIES - FTSE 100

----------

Halma said it has completed three acquisitions for a total of GBP48.8 million and sold electronic security systems provider Texecom for GBP65 million. In the Safety sector, Halma acquired the Ramtech Group for GBP15.5 million in cash. In the Environmental & Analysis sector, Halma's pipeline inspection systems business, Mini-Cam, acquired Dancutter, a Danish designer and manufacturer of trenchless pipeline rehabilitation equipment for EUR18 million. Halma also bought Sensitron, a gas detection company based in Milan, Italy, for EUR21 million in cash. CEO

----------

BT Group is set to poach ASOS Chair Adam Crozier to be its own chair, the Sunday Times reported over the weekend. According to the newspaper, Crozier will resign from the online fashion retailer to focus on the telecoms firm, although he will stay on as chair of Whitbread and private data analytics business Kantar. Crozier beat three other candidates for the BT role, the newspaper reported, without saying where it got the information from. The 57-year-old was formerly chief executive of Royal Mail, ITV and the Football Association. At BT, he will be expected to stabilise the board after the resignation of previous chair Jan du Plessis, whose relationship with Chief Executive Philip Jansen broke down.

----------

COMPANIES - FTSE 250

----------

Philip Morris International raised its bid for asthma treatment firm Vectura to 165 pence per share, besting the 155p offer from private equity firm Carlyle to which Vectura had agreed on Friday. The new offer values Vectura at GBP1.02 billion. PMI previously had offered 150p per Vectura share.

----------

Shipping services firm Clarkson reported a robust set of interim earnings with strong trading across all areas of the business. For the six months to June 30, revenue was GBP190.1 million, up 5.4%, GBP180.4 million last year, and pretax profit rose 31% to GBP27.3 million from GBP20.9 million. The company declared an interim dividend of 27p, up 8% from 25p paid out at the halfway stage last year. CEO Andi Case said: "The company generated significantly increased profits in the first half of the year, aided by a robust performance in our Broking division and a strong recovery from our Financial division. I am also excited by the progress and momentum that our Sea/ platform is building. "We are confident in the outlook for Clarksons, which is well placed to capitalise on an improving demand-supply dynamic within shipping, offshore and renewables and from the wider global economic recovery."

----------

COMPANIES - MAIN MARKET AND AIM

----------

Germany's Delivery Hero has built a 5.1% stake in UK rival Deliveroo, crossing the 5% threshold on Friday, according to a regulatory release on Monday.

----------

Virgin Atlantic Airways is planning to list on the London Stock Exchange to take advantage of investors expectations of a quick economic recovery in international travel, the Financial Times reported on Sunday. The Crawley, West Sussex-based long-haul carrier has been talking to fund managers about a listing as early as this autumn, the newspaper reported, citing "a person familiar with the matter". The initial public offering will be led by bankers from Citigroup and Barclays, the FT said, noting this was first reported by Sky News. Virgin boss Richard Branson would likely lose his majority stake, it noted.

----------

COMPANIES - GLOBAL

----------

China Telecom could raise more than USD8 billion in a Shanghai initial public offering that would be the biggest this year, months after it was delisted in the US amid Washington's stand-off with Beijing. The firm said it had priced its offer at 4.53 yuan per share, which would be worth CNY47.1 billion, about USD7.3 billion, according to a filing with the Shanghai Stock Exchange on Friday. However, if an over-allotment option was exercised that would jump to CNY54 billion, or USD8.4 billion, Bloomberg News said. China Telecom was delisted by the New York Stock Exchange in January along with fellow state-owned telecoms firms China Mobile and China Unicom following an executive order by former president Donald Trump.

----------

Monday's Shareholder Meetings

NextEnergy Solar Fund Ltd - AGM

Shefa Gems Ltd - GM re mining unit sale and share consolidation

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.